Trust Guideline for Management of Faltering Growth (Failure to Thrive) in Babies and Young Children.

Similar documents
A Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children

Trust Protocol for the Administration of Intravenous Methylprednisolone for Thyroid Eye Disease A Protocol. The Clinical Investigation Unit (CIU)

Trust Guideline for the inclusion of women at High Risk of Breast Cancer in the NHS Breast Screening Programme

Trust Guideline on Routine Oxygen Saturation Measurement on the New-born (Pulse Oximetry)

A Trust Guideline for the Management of. Bronchiolitis in Infants and Children under the age of 24 months

Joint Trust Guideline for the Management of Methylprednisolone Sodium Succinate Infusion for Child or Young Person A Clinical Guideline

Guideline for the Use of Granulocyte Colony Stimulating Factor (G-CSF) for Adults in Oncology and Haematology

By: For: Division responsible for document: Key words: Name and job title of document author: Name and job title of document author s Line Manager:

Trust Guideline for the Prevention of Tuberculosis and Management of Tuberculosis Exposure in Health Care Workers

Trust Guideline for the Management of: Abnormal Pre-operative Thyroid Function Tests in Adults. Anaesthetists Abnormal Pre-op Thyroid Function Test

Joint Trust Guideline for the Management of: CFS/ME (Chronic Fatigue Syndrome / Myalgic Encephalopathy) in Children and Young People

Trust Guideline for the Management of Sedation in Painless Imaging Procedures in Children

History taking in paediatrics PROF. DR STANISŁAW POPOWSKI REGIONAL SPECIALIZED CHILDREN S HOSPITAL IN OLSZTYN

Dietetic Assessment of Children with Cystic Fibrosis

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use

Glucocorticoid replacement, Steroids, Acute Illness Dr Rupa Ahluwalia, Consultant Physician (NNUH)

Joint Trust Clinical Guideline for Monitoring of patients with Guillain Barré Syndrome (GBS)

Division 2, Surgical and Anaesthetics Directorates All surgical and anaesthetics staff Patients with an implanted spinal cord stimulator For:

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults

Western Health Specialist Clinics Access & Referral Guidelines

Trust Guideline for the management of Parapneumonic Effusion in children

Information for health professionals

Guidelines for the prescribing of specialist infant formula in primary care: Luton and Bedfordshire

Appropriate prescribing of specialist infant formula feeds

Joint Trust Guideline for the Use of Intravenous Vancomycin in Paediatrics

Trust Guideline for the Management of Patient Controlled Analgesia (PCA) in Adults

Trust Guideline for the Management of: Condition or Procedure in Adults and / or Children

Evaluation of Failure to Thrive in a Young Child: Case Example of Jeff. Andrew Hsi, MD, MPH Family Medicine Pediatric Grand Rounds, 8 August 2012

Nutrition. A Guide. A guide to the nutrition of babies and children with liver disease

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Children s Services Medical Guideline

Nutritional Assessment & Monitoring of Hospitalized Children

Trust Guideline for the Management and Administration of Intravenous Iron in Adults under the Gastroenterology Directorate

Trust Guidelines for the Diagnosis and Management of Gestational Diabetes Mellitus (GDM)

Falls The Assessment, Prevention and Management of Patient Falls (Adult Services) 1.34

Malnutrition in Adults: Guidelines for Identification and Treatment

History Taking 3rd year Lecture. Thembi Katangwe 1st March 2011

Clinical Assessment Tool

MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Neonatal and infant health. What to look out for in babies up to 6 months old. Anoo Jain Neonatal Consultant

Case Study. Synopsis. Introduction/overview. Hannah Roberts Specialist Paediatric Dietitian County Durham and Darlington Foundation Trust

A Crash Course in Failure to Thrive April 5, Kelly E. Wood, MD Clinical Assistant Professor Stead Family Department of Pediatrics

BEST PRACTICE GUIDELINE

INFANT FEEDING DIFFICULTIES

Trust Guideline for the Management of Children with Hydrocephalus and Ventriculo-peritoneal Shunts

General Paediatrics Syllabus

Trust Guideline for the Investigation of Incidental Adrenal Masses in Adults

NUTRITIONAL REQUIREMENTS

Guideline scope Neonatal parenteral nutrition

Nutritional Interventions for Children with Cystic Fibrosis

Joint Trust Guidelines for Management of Central Venous Catheter Infection in Children Receiving Parenteral Nutrition

Diabetes Emergency Caesarean section or other unplanned surgery (GL822)

Food allergy in children. nice bulletin. NICE Bulletin Food Allergy in Chlidren.indd 1

World Health Organization Growth Standards. First Nations and Inuit Health Alberta Region: Training Module May 2011

Staff Quiz. 1. Serial measurements are necessary for identification of growth trends in children. TRUE / FALSE

Starship Paediatric Respiratory and Sleep Medicine Department Outpatient Referral Criteria General Principles

Names of document authors Line Dr David Booth (Clinical Director in Paediatrics) Mr Charles Graham (Head of Technical Cardiology)

2010 National Audit of Dementia (Care in General Hospitals) North West London Hospitals NHS Trust

Joint Trust Guideline for 72 hour fast for investigation of spontaneous hypoglycaemia in adults For use in:

Clinical guideline Published: 24 September 2008 nice.org.uk/guidance/cg72

2010 National Audit of Dementia (Care in General Hospitals)

The Cystic Fibrosis Service at GOSH

Hypoglycaemia (low blood sugar) & ketotic hypoglycaemia

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE DRUG: LISDEXAMFETAMINE PROTOCOL NUMBER: CV 57

Integrated Care Pathway (ICP) for the. Management of clozapine INPATIENT INITIATION

The use of a 1.5kcal/ml whey peptide based feed to help promote gastric emptying and feed tolerance in a paediatric patient with neurodisability.

Seasonal Influenza in Pregnancy and Puerperium Guideline (GL1086)

GUIDELINE FOR THE MANAGEMENT OF PROLONGED JAUNDICE IN BABIES. All babies admitted to hospital with prolonged jaundice

Appendix 9B. Diagnosis and Management of Infants with Suspected Cow s Milk Protein Allergy.

FAILURE TO THRIVE: RETHINKING OUR TREATMENT GOALS

2010 National Audit of Dementia (Care in General Hospitals) Guy's and St Thomas' NHS Foundation Trust

SHARED CARE PRESCRIBING GUIDELINE

2010 National Audit of Dementia (Care in General Hospitals) Chelsea and Westminster Hospital NHS Foundation Trust

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Nutrition support in adults: oral supplements, enteral and parenteral feeding.

Trust Guideline for the Management of: A Neonate with Difficult Airway

Case Study. The 4-year journey of feeding intolerance of an enterally-fed child from 9 months of age. Synopsis. Introduction/Overview

MUST and Malnutrition

NICE Action Plan 6/13 Transient loss of consciousness ('blackouts') management in adults and young people NICE CG 109 December 2013

Joint Trust Guideline for the Initial Management of Congenital Talipes

SCRIPT: Module 3. Interpreting the WHO Growth Charts for Canada SLIDE NUMBER SLIDE SCRIPT

Bedford Borough, Central Bedfordshire and Luton Child Death Overview Process Panel Annual Report 1 April March 2017

Functional Gut Disorders in Infants

Neonatal Hypoglycaemia Guidelines

Bournemouth, Dorset and Poole Prescribing Forum

Appropriate Prescribing of Specialist Infant Formulae

Trust Guideline for the Administration of Bisphosphonate Therapy (Pamidronate or Zoledronic Acid) in Children

Epilepsy12 Round 3 Organisational Audit dataset

COMMON PROBLEMS IN PAEDIATRIC GASTROENTEROLOGY AKSHAY BATRA CONSULTANT PAEDIATRIC GASTROENTEROLOGIST

Ratified by: Care and Clinical Policies Date: 17 th February 2016

Urinary tract infection (UTI) in children. Children s Hospital. Information for Parents and Carers DRAFT. University Hospitals of Leicester.

Trust Guideline for the Management of: Adult patients requiring anticoagulation with Warfarin (including reversal)

Guideline for the Prescribing of Oral Nutritional Supplements in Adults (NUT2)

Care Homes - Homely Remedies Protocol

11/8/12. KERNICTERUS: The reason we have to care about bilirubin. MANAGING JAUNDICE IN THE BREASTFEEDING INFANT AKA: Lack of Breastfeeding Jaundice

A Framework of Competences for Special Interest Module in Paediatric Epilepsies

GROUP PROTOCOL FOR THE MANAGEMENT OF CONSTIPATION IN PATIENTS IN CLOZAPINE CLINICS. Version 1 (reviewed unchanged January 2018)

PedsCases Podcast Scripts

Patient Group Directions Policy

Transcription:

Trust Guideline for Management of Faltering Growth (Failure to Thrive) in. A Clinical Guideline For use in: By: For: Division responsible for document: Women and Children Key words: Buxton Ward, Children s Assessment Unit, Jenny Lind Outpatients Paediatric SHOs, Registrars, Consultants Children under 5 years old with unexplained faltering growth. Faltering growth, failure to thrive Name and job title of document author: Barbara Alden, Paediatric SHO Caroline Kavanagh, Consultant Paediatrician Name of document author s Line Manager: David Booth Job title of author s Line Manager: Chief of Division Supported by: Dr Ambadkar, Paediatrician (JPUH) and Paediatric Medical Staff Assessed and approved by the: Clinical Guidelines Assessment Panel (CGAP) Date of approval: 08 March 2018 Ratified by or reported as approved to (if applicable): To be reviewed before: This document remains current after 08 March 2021 this date but will be under review To be reviewed by: Dr Caroline Kavanagh Reference and / or Trust Docs ID No: ID No: 12256 Version No: 2.2 Description of changes: Compliance links: (is there any NICE related to guidance) If Yes - does the strategy/policy deviate from the recommendations of NICE? If so why? Clinical Standards Group and Clinical Safety and Effectiveness Sub-Board Joint header added. None N/A This guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes. Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 1 of 12

Trust Guideline for Management of Faltering Growth (Failure to Thrive) in. The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document. Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 2 of 12

Quick reference guideline Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 3 of 12

Objectives 1) To facilitate early recognition of failure to thrive 2) To ensure thorough and methodical investigation of all cases of failure to thrive. 3) To avoid unnecessary investigations or need for repeated painful procedures e.g. venepuncture. Rationale Failure to thrive or faltering growth, is defined as a significant interruption in the expected rate of growth compared to other children of similar age and sex during early childhood. It is a persistent, gradually evolving phenomenon which can frequently and relatively easily go undetected, particularly in children who do not frequently access healthcare. Faltering growth is not a finite diagnosis; rather it is a symptom of other underlying organic or non-organic problems. In the long-term, faltering growth is associated with reduced adult height, impaired academic performance and increased incidence of behavioural and psychological disturbance. Early recognition, investigation and diagnosis of the underlying causes of faltering growth rely on adequate awareness and vigilance of all healthcare professionals. Faltering growth may not be a child s presenting complaint when seeking healthcare advice, hence it is essential that all children are assessed to screen for evidence of this problem whenever they are seen. This guideline aims to provide an outline for the initial assessment and investigation of children highlighted as having signs of faltering growth. As the underlying causes are wide ranging and often multifactorial please refer to other relevant guidelines to investigate specific diagnoses after completing the basic checks listed here. Broad recommendations Diagnostic criteria Failure to thrive should be considered in children who are over 6 weeks of age with a combination of the following: 1) Children with weight crossing 1 centile space where birthweight or previous weight was below the 9 th centile; or weight crossing 2 centile spaces where weight was Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 4 of 12

between 9 th -91 st centiles; or weight crossing 3 centile spaces where weight was above the 91 st centile. 2) Growth persistently below 2 nd centile (weight and/or height) 3) Asymmetrical weight and head circumference measurements (e.g. weight on 5 th centile, head circumference on 50 th centile.) Be aware of other conditions which present with the same signs as above but would not be in keeping with an overall impression of failure to thrive e.g. familial small stature (+/- catch down growth), Russell-Silver syndrome, hydrocephalus. Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 5 of 12

Identifying children at risk All children admitted to NNUH, whether acutely, electively or seen in outpatient clinic should have height and weight measured and plotted on an age appropriate centile chart. All children under 2 years, and all over 2 years who are found to be below the normal height or weight range (<2 nd centile) or crossing down 2 centiles should also have head circumference measured and plotted. Wherever possible these measurements should be compared with previous ones recorded in the child s handheld health record ( red book ). Medical History A thorough history, ideally from the child s primary care giver(s) is key and in most cases, will help determine whether a cause is likely to be organic or non-organic. History must include: Presentation: when was concern first raised, by whom, why? Attempts made to improve growth so far, any period of normal growth? Birth history: gestation, antenatal issues, condition at birth, jaundice, any treatment received in neonatal period. Feeding history: Breast/bottle fed, type of milk used, volume and frequency of feeds, age at weaning, amount and type of fluids taken (i.e. milk/juice etc.) food intolerances/allergies, reflux symptoms. It is often useful to ask parents to describe a typical day s intake. A food diary recording food intake and mealtime issues may be useful. In milk fed babies consider whether any of the following are contributing to faltering growth: Ineffective suckling in breast fed infants Ineffective bottle feeding Feeding patterns or routines used Feeding aversion Carer-infant interaction / how carer responds to feeding cues Physical disorders affecting feeding In weaned babies/children consider whether any of the following are contributing to faltering growth: Mealtime arrangements and practices Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 6 of 12

Trust Guideline for Management of Faltering Growth (Failure to Thrive) in Types of food offered Appetite Food aversion / avoidance Carer-child interactions Physical disorders affecting feeding Medical issues: Specifically enquire about each system Respiratory/cardiac: breathing problems, wheeze, chronic cough, recurrent infections, cyanotic episodes, pallor or sweating (especially with feeds), tachypnoea Gastrointestinal: Passage of meconium, stool frequency and description, vomiting, abdominal pain or distension. Neurological/development: Milestones so far, vision and hearing, seizures. Other: skin rashes/birthmarks, joint pain or swelling, infectious diseases, urinary problems. Medications: any medicines used and why, vaccination history, allergies. Family and social history: Complete a detailed family tree including name, ages and ethnicity of parents, siblings and additional people within family (step-parents, half-siblings etc.). Relevant medical issues in family members (e.g. cystic fibrosis (C.F), cardiac disease, familial short stature). Any recent change in family structure, childcare, contact with social services, name of health visitor and any other professionals involved. Initial investigations Full physical examination: to include height, weight, head circumference, respiratory, cardiovascular, gastrointestinal and neurological examinations, fundoscopy where possible. Fully undress the child to check for skin lesions. Calculate mid-parental height where possible. Additional concern should be raised by a child s height centile that is more than 2 centile spaces below the mid parental height centile. In a child, over 2 years calculate the BMI centile Observations: Pulse and respiratory rate, blood pressure, oxygen saturations (pre-and post-ductal measurements), temperature. Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 7 of 12

If a clear organic cause is not identified after the first consultation, it is sensible to check family background with on call social worker to rule out ongoing concerns. Further investigations Beyond the baseline tests looking for an organic cause (see quick reference guide), further investigations will mostly be guided by findings of history and examination. Please refer to relevant trust guidelines for investigations for, and initial management of, other specific medical conditions. Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 8 of 12

Initial management If initial history and examination do not reveal any signs of specific organic illness then the most common cause of faltering growth is inadequate nutrition. This can be intentional or non-intentional and many parents are unaware of the nutritional requirements of small children. Parents/carers should be offered advice on positive feeding practices, including: Appropriate food choices in terms of quantity, type and texture for a child s developmental stage Establishing regular eating schedules Encouraging relaxed and enjoyable mealtimes Avoiding coercive feeding Setting reasonable boundaries for mealtime behaviour while avoiding punitive approaches Making sure mealtimes are not too brief or too long Eating together as a family or with other children Encouraging young children to feed themselves Allowing young children to be messy with food Involvement of paediatric dietician may be useful if further advice is required on increasing nutrient density of diet beyond that achieved through basic advice on food choices, e.g. if considering short term dietary fortification with energy rich foods. In children where the diagnosis is either uncertain, or where there is a high suspicion of a non-organic cause (i.e. inadequate feeding), before further, potentially invasive investigations are done, review by the paediatric dietician and trial of tailored meal plan is advised. Children with faltering growth should not be kept as inpatients unless they are acutely unwell or there is specific intervention that requires this; e.g. commencing tube feeding / safeguarding concerns. The decision of whether to allow a child to be discharged with close follow up while a trial of feeding takes place will take into account: 1.) Severity of the faltering growth and overall physical condition of the child. 2.) How likely an alternative diagnosis is felt to be? Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 9 of 12

3.) Safeguarding concerns e.g. neglect. 4.) Logistic implications e.g. availability of patient transport for follow ups, availability of inpatient beds. Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 10 of 12

Weight Monitoring Children with faltering growth will require ongoing follow up under a named consultant while there are concerns around faltering growth. Frequency of weight measurement is dependent on age and degree of progress but should not usually exceed: Weekly in babies age 1-6 months Fortnightly in babies age 6-12 months Monthly in children over 1 year Weight loss after the first weeks of life is unusual and may justify more frequent monitoring than recommended above. Child s length or height should be monitored no more often than every 3 months. Management after feeding trial Good weight gain Liaise with dietician, health visitor, safeguarding teams (if felt to be necessary by consultant). Child may need a pre-discharge planning meeting if an inpatient. Ensure close follow up and weight monitoring as described above until growth is steady. Poor weight gain despite sustained period of adequate intake: Likely organic cause of faltering growth if meal plan well followed. Ensure meal plan was followed strictly. If not, then explore reasons why. Baseline investigations should include urine MC&S, FBC and blood film, U&E, LFT and bone profile, coeliac screen and thyroid function tests. Further, more specific investigations will be dependent on presentation but may include: stool culture, abdominal USS, cardiac echo, karyotype, micro-array +/- other specific genetics (dependent on clinical features). Consider short term dietary fortification using energy dense food or trial of oral liquid nutritional supplement under guidance of dietician. Reassess need regularly, taking into account weight change, linear growth, intake of other foods, tolerance, adherence and views of the carer. Enteral tube feeding should only be used with appropriate MDT involvement and with specific agreements on: Goals of treatment (e.g. target weight) Strategy for withdrawal when goals are reached Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 11 of 12

Clinical audit standards / monitoring compliance 1. All children presenting to inpatient or outpatient paediatrics will have height and weight measured and documented in the medical notes in an age appropriate growth chart. 2. All children under 2 years will have head circumference measured. 3. A diagnosis of faltering growth will be considered in all children height/weight parameters within the range described above. Summary of development and consultation process undertaken before registration and dissemination The guideline was drafted by the authors listed above and circulated among the Paediatric Consultants and other medical staff, who have agreed the final content. Distribution list / dissemination method Buxton Ward, Children s Assessment Unit References / Source Documents 1. Krugman SD et al, Failure to thrive. Am Fam Physician 2003;68:(5):879 84. 2. Olsen EM et al, Failure to thrive: the prevalence and concurrence of anthropometric criteria in a general infant population. Arch Dis Child 2007;92: (2):109 14. 3. Wright CM, Identification and management of failure to thrive: a community perspective. Arch Dis Child 2000;82: (1):5 9 Available via Trust Docs Version: 2.2 Trust Docs ID: 12256 Page 12 of 12